[Effect of HDAC Inhibitor Chidamide on PD-L1 Expression in Peripheral T-Cell Lymphoma].

OBJECTIVE

To explore the role of chidamide in the regulatory mechanism of PD-1/PD-L1 immune escape signaling pathway in peripheral T-cell lymphoma.

METHODS

Jurkat cell line was treated with different concentrations of chidamide. The changes of PD-L1 and pathway gene mRNA expression and PD-L1 protein expression on cell surface were detected by fluorescence quantitative PCR and flow cytometry after treatment.

RESULTS

Chidamide upregulated mRNA expression in Jurkat cell line in a dose-dependent manner (=0.989). The mRNA expression of in 5.0 μmol/L group was 15.4 times higher than that in the control group. The proportion of PD-L1 positive cells in Jurkat cell line was less than 0.5%. Chidamide upregulated PD-L1 protein expression on Jurkat cell surface. Chidamide upregulated the mRNA expression of and in Jurkat cell line. The level of up-regulation was obvious in high concentration group (5.0 μmol/L group). Meanwhile, the mRNA expression of and , the negative regulatory genes upstream of the T pathway, were up-regulated.

CONCLUSION

In peripheral T-cell lymphoma, chidamide may up-regulate the expression of cell surface PD-L1 and induce T-cell chemokines by upregulation of expression, thus improving the reaction rate of PD-1 monoclonal antibody and T-cell toxicity.